Drug recall · August 5, 2026
Mycophenolate Mofetil for Injection USP recall
Why: Presence of precipitate
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
- Lots / codes
Lot #: 3241653, Exp 4/30/2027
- Quantity
- 5688 vials
- Company
- Mylan Pharmaceuticals Inc, Morgantown, WV
- Distribution
- USA Nationwide
- Initiated
- July 2, 2026 · Voluntary: Firm initiated
- Classified
- August 4, 2026
- Reported
- August 5, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mycophenolate mofetil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.